Skip to content

Construction of a National Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases

Construction of a National Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases and Technical Promotion of Standardized Diagnosis and Treatment Programs

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05687461
Enrollment
10000
Registered
2023-01-18
Start date
2022-07-01
Completion date
2025-07-31
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality Control

Keywords

Quality Control, Respiratory Diseases

Brief summary

1. Build a national diagnosis and treatment quality control platform for major respiratory diseases It will establish and improved a National diagnosis and Treatment quality control Platform for major respiratory diseases, and form a three-level network of diagnosis and treatment quality control for major respiratory diseases with a three-level system structure of national, provincial and hospital. 2. Promote standardized diagnosis and treatment techniques for major respiratory diseases Relying on the specialized disease collaboration group or innovative unit model, all-round and hierarchical precision training and teaching are carried out to popularize and promote standardized diagnosis and treatment technology schemes for major respiratory diseases, so as to achieve the homogenization of diagnosis and treatment level for major respiratory diseases.

Detailed description

1. Build a national diagnosis and treatment quality control platform for major respiratory diseases Cooperate with the Medical Administration Administration of the National Health Commission, the Medical Administration Institute of the National Health Commission and the National Center for Respiratory Disease Medical Quality Control to integrate the existing diagnosis and treatment quality indicators and data from NCIS (National Medical Quality Management and Control Information Network) and HQMS (Hospital Quality Monitoring System), and determine the definition, data sources and collection rules of core quality control indicators. It has established and improved a National diagnosis and Treatment quality control Platform for major respiratory diseases, and formed a three-level network of diagnosis and treatment quality control for major respiratory diseases with a three-level system structure of national, provincial and hospital. 2. To master the incidence trend and diagnosis and treatment quality of major respiratory diseases Through the big data integration and analysis function of the National Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases, the incidence trend and law of various major respiratory diseases are mastered. To understand the difference in the diagnosis and treatment quality of respiratory diseases in hospitals of different regions and levels, including the allocation of related resources (such as personnel, technology, equipment, information construction, etc.); The status of diagnosis and treatment ability (prevention, diagnosis, treatment, rehabilitation, etc.); Current burden of disease (e.g. morbidity, case fatality rate, average length of stay, average cost of stay, etc.) 3. Promote standardized diagnosis and treatment techniques for major respiratory diseases Relying on the specialized disease collaboration group or innovative unit model, through online and offline academic conferences, continuing medical education, specialized training, visits and exchanges, case discussions, knowledge competitions, wechat public accounts and other new media means, regularly focus on prevention, diagnosis, treatment, rehabilitation, management, quality control and many other aspects. Comprehensive and hierarchical precision training and teaching should be carried out to popularize and promote standardized diagnosis and treatment technology schemes for major respiratory diseases, so as to achieve the homogenization of diagnosis and treatment levels for major respiratory diseases.

Interventions

OTHERBuild a national diagnosis and treatment quality control platform for major respiratory diseases

1. Build a national diagnosis and treatment quality control platform for major respiratory diseases 2. To master the incidence trend and diagnosis and treatment quality of major respiratory diseases 3. Promotion of standardized diagnosis and treatment techniques for major respiratory diseases

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL

Inclusion criteria

I. For patients at high risk for VTE 1) Have an expected hospital stay of ≥72 hours for medical and/or surgical treatment II. For patients diagnosed with VTE 1\) With clearly diagnosed of deep vein thrombosis or pulmonary thromboembolism

Exclusion criteria

I. For patients at high risk for VTE 1. VTE identified on CTPA or lower extremity vein ultrasound at or any time before enrollment 2. Requiring a full dose of anticoagulant treatment before enrollment (e.g., recent VTE, atrial fibrillation).

Design outcomes

Primary

MeasureTime frameDescription
A respiratory quality control network platform has been established2025.01A complete national quality control network platform for the diagnosis and treatment of major respiratory diseases with multi-source data has been built

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026